| Identification of ROS using oxidized DCFDA and flow-cytometry E Eruslanov, S Kusmartsev Advanced protocols in oxidative stress II, 57-72, 2010 | 1324 | 2010 |
| Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species S Kusmartsev, Y Nefedova, D Yoder, DI Gabrilovich The Journal of Immunology 172 (2), 989-999, 2004 | 1033 | 2004 |
| Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells CA Corzo, MJ Cotter, P Cheng, F Cheng, S Kusmartsev, E Sotomayor, ... The Journal of Immunology 182 (9), 5693-5701, 2009 | 884 | 2009 |
| All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination S Kusmartsev, F Cheng, B Yu, Y Nefedova, E Sotomayor, R Lush, ... Cancer research 63 (15), 4441-4449, 2003 | 569 | 2003 |
| STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion S Kusmartsev, DI Gabrilovich The Journal of Immunology 174 (8), 4880-4891, 2005 | 549 | 2005 |
| Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer Y Nefedova, M Huang, S Kusmartsev, R Bhattacharya, P Cheng, R Salup, ... The Journal of Immunology 172 (1), 464-474, 2004 | 542 | 2004 |
| Role of immature myeloid cells in mechanisms of immune evasion in cancer S Kusmartsev, DI Gabrilovich Cancer Immunology, Immunotherapy 55, 237-245, 2006 | 471 | 2006 |
| Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation SA Kusmartsev, Y Li, SH Chen The Journal of Immunology 165 (2), 779-785, 2000 | 460 | 2000 |
| Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells S Kusmartsev, S Nagaraj, DI Gabrilovich The journal of immunology 175 (7), 4583-4592, 2005 | 422 | 2005 |
| COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells V Prima, LN Kaliberova, S Kaliberov, DT Curiel, S Kusmartsev Proceedings of the National Academy of Sciences 114 (5), 1117-1122, 2017 | 412 | 2017 |
| Immature myeloid cells and cancer-associated immune suppression S Kusmartsev, DI Gabrilovich Cancer immunology, immunotherapy 51, 293-298, 2002 | 390 | 2002 |
| Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species S Kusmartsev, DI Gabrilovich Journal of Leucocyte Biology 74 (2), 186-196, 2003 | 384 | 2003 |
| Reversal of myeloid cell–mediated immunosuppression in patients with metastatic renal cell carcinoma S Kusmartsev, Z Su, A Heiser, J Dannull, E Eruslanov, H Kübler, ... Clinical Cancer Research 14 (24), 8270-8278, 2008 | 364 | 2008 |
| Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma S Kusmartsev, E Eruslanov, H Kubler, T Tseng, Y Sakai, Z Su, S Kaliberov, ... The Journal of Immunology 181 (1), 346-353, 2008 | 308 | 2008 |
| Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway I Daurkin, E Eruslanov, T Stoffs, GQ Perrin, C Algood, SM Gilbert, ... Cancer research 71 (20), 6400-6409, 2011 | 229 | 2011 |
| Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer S Kusmartsev, DI Gabrilovich Cancer and Metastasis Reviews 25, 323-331, 2006 | 226 | 2006 |
| Circulating and tumor‐infiltrating myeloid cell subsets in patients with bladder cancer E Eruslanov, M Neuberger, I Daurkin, GQ Perrin, C Algood, P Dahm, ... International journal of cancer 130 (5), 1109-1119, 2012 | 221 | 2012 |
| Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in … E Eruslanov, I Daurkin, J Ortiz, J Vieweg, S Kusmartsev Journal of leukocyte biology 88 (5), 839-848, 2010 | 174 | 2010 |
| Mechanisms of immune evasion in bladder cancer PL Crispen, S Kusmartsev Cancer Immunology, Immunotherapy 69 (1), 3-14, 2020 | 148 | 2020 |
| Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer B Yu, S Kusmartsev, F Cheng, M Paolini, Y Nefedova, E Sotomayor, ... Clinical cancer research 9 (1), 285-294, 2003 | 134 | 2003 |
Dmitry GabrilovichChief Scientist, Cancer Immunology, AstraZenecaE-mail confirmado em astrazeneca.com
